novabio therapeutics
We are committed to the research and development and clinical application of regulatory T cells. Focus on unmet medical needs.
INNOVATION
01
Research field
Saierxin Biomedical Technology focuses on two major diseases
• Autoimmune diseases (AID)
• Neurodegenerative diseases or disorders (NDD)。
02
About Treg（Introduction to inhibitory T cells）
Regulating T cells (Treg) in inhibitory T cells were discovered in 1995 as a group of T cell subgroups characterized by cell phenotypic expressions such as Foxp3, CD25 and CD4.
R&D and Exploration
- Platform for immunology and molecular biology
- Cell process development platform
- Gene editing platform
News
With the latest technology and information, NOVABIOTX has always strived to be at the forefront of the industry.
Careers
Achieve career and fulfill oneself
Working at NOVABIOTX
We're looking for business partners who share the same values as Serexin and are willing to contribute to the team, working together to provide innovative therapies for patients worldwide.